Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Shah, Khalid  [Clear All Filters]
2024
Choi SHugh, Stuckey DW, Pignatta S, Reinshagen C, Khalsa JKaur, Roozendaal N, Martinez-Quintanilla J, Tamura K, Keles E, Shah K. Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas. Clin Cancer Res. 2024;30(9):1993.
Valdes PA, Yu C-CJay, Aronson J, Ghosh D, Zhao Y, An B, Bernstock JD, Bhere D, Felicella MM, Viapiano MS, et al. Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowding. Sci Transl Med. 2024;16(732):eabo0049.
2023
Chen K-S, Reinshagen C, Van Schaik TA, Rossignoli F, Borges P, Mendonca NClaire, Abdi R, Simon B, Reardon DA, Wakimoto H, et al. Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Sci Transl Med. 2023;15(677):eabo4778.
Rossignoli F, Hoffman D, Atif E, Shah K. Developing and characterizing a two-layered safety switch for cell therapies. Cancer Biol Ther. 2023;24(1):2232146.
Van Schaik TA, Moreno-Lama L, Farzani TAligholipo, Wang M, Chen K-S, Li W, Cai L, Zhang YShrike, Shah K. Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors. Biomed Pharmacother. 2023;162:114665.
Liu L, Van Schaik TA, Chen K-S, Rossignoli F, Borges P, Vrbanac V, Wakimoto H, Shah K. Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice. Front Immunol. 2023;14:1324618.
Moleirinho S, Kitamura Y, Borges PSGN, Auduong S, Kilic S, Deng D, Kanaya N, Kozono D, Zhou J, Gray JJ, et al. Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer. Stem Cells Transl Med. 2023.
Kanaya N, Kitamura Y, Vazquez MLopez, Franco A, Chen K-S, Van Schaik TA, Farzani TAligholipo, Borges P, Ichinose T, Seddiq W, et al. Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Sci Transl Med. 2023;15(698):eade8732.
Liu C, Shah K. Taming CAR T cell therapy toxicity. Nat Mater. 2023.
2022
Hajji N, Garcia-Revilla J, Soto MSarmiento, Perryman R, Symington JJ, Quarles CC, Healey DR, Guo Y, Orta-Vázquez MLuis, Mateos-Cordero S, et al. Arginine deprivation alters microglia polarity and synergises with radiation to eradicate non arginine auxotrophic glioblastoma tumors. J Clin Invest. 2022.
Liu L, Huh JR, Shah K. Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS. EBioMedicine. 2022;77:103908.
2021
Ishii Y, Kolluri KK, Pennycuick A, Zhang X, Nigro E, Alrifai D, Borg E, Falzon M, Shah K, Kumar N, et al. BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma. J Biol Chem. 2021:101223.
2020
Jiang L, Wang Y-J, Zhao J, Uehara M, Hou Q, Kasinath V, Ichimura T, Banouni N, Dai L, Li X, et al. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy. Cell. 2020;183(5):1219-1233.e18.
Mineo M, Lyons SM, Zdioruk M, von Spreckelsen N, Ferrer-Luna R, Ito H, Alayo QA, Kharel P, Larsen AGiantini, Fan WY, et al. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus. Mol Cell. 2020.
2019
Tanaka S, Luk S, Kiyokawa J, Onozato ML, A Iafrate J, Shah K, Martuza RL, Rabkin SD, Batchelor TT, Cahill DP, et al. Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy. Sci Rep. 2019;9(1):139.
2016
Choi SHugh, Shah K. Engineered bifunctional proteins and stem cells: next generation of targeted cancer therapeutics. Discov Med. 2016;22(120):157-166.
2015
Bhere D, Shah K. Stem Cell-Based Therapies for Cancer. Adv Cancer Res. 2015;127:159-189.
Bagci-Onder T, Du W, Figueiredo J-L, Martinez-Quintanilla J, Shah K. Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells. Brain. 2015.
2014
Stuckey DW, Shah K. Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer. 2014.
Duebgen M, Martinez-Quintanilla J, Tamura K, Hingtgen S, Redjal N, Wakimoto H, Shah K. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. J Natl Cancer Inst. 2014;106(6).